When clinical trials make history: Demonstrating efficacy of new antiepileptic drugs as monotherapy

Epilepsia

Volumn 51, Issue 10, 2010, Pages 1933-1935

  Perucca, Emilio ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Epilepsy; Historical controls; Regulatory requirements

Indexed keywords

ANTICONVULSIVE AGENT; BRIVARACETAM; ESLICARBAZEPINE ACETATE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PLACEBO; TIAGABINE; TOPIRAMATE;

CLINICAL TRIAL; DRUG EFFICACY; EPILEPSY; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

ANTICONVULSANTS; CONTROL GROUPS; CONTROLLED CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUGS, INVESTIGATIONAL; EPILEPSY; EUROPEAN UNION; HUMANS; RESEARCH DESIGN; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78649249320     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02589.x     Document Type: Review

References (19)

1. Beydoun A, Kutluay E,. (2003) Conversion to monotherapy: clinical trials in patients with refractory partial seizures. Neurology 60 (suppl 4): S13-S25.
2. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ, For the Levetiracetam Monotherapy Study Group. (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68: 402-408.
3. CPMP (Committee for Proprietary Medicinal Products) (2000). Note for guidance on clinical investigation of medicinal products in the treatment of epileptic disorders (CPMP/EWP/566/98 rev 1), London. Available at website:. Accessed on November 16, 2009.
4. French JA, Wang S, Warnock B, Temkin N,. (2010) Historical control monotherapy design in the treatment of epilepsy. Epilepsia 51: 1936-1943.
5. Gallahan WC, Case D, Bloomfeld RS,. (2010) An analysis of the placebo effect in Crohn's disease over time. Aliment Pharmacol Ther 31: 102-107.
6. Guekht AB, Korczyn AD, Bondareva IB, Gusev EI,. (2010) Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav 17: 64-69.
7. ICH (International Conference on Harmonisation) (2001) ICH Topic E10: Choice of control group and related issues in clinical trials. CPMP/ICH/364/96, London. Available at website:. Accessed on January 2, 2010.
8. Leber PD,. (1989) Hazards of inference: the active control investigation. Epilepsia 30 (suppl 1): S57-S63. Discussion S64-68.
9. Perucca E,. (2008) Designing clinical trials to assess antiepileptic drugs as monotherapy: difficulties and solutions. CNS Drugs 22: 917-938.
10. Perucca E, Tomson T,. (1999) Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications. Epilepsy Res 33: 247-262.
11. Perucca E, Dulac O, Shorvon SD, Tomson T,. (2001) Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs 15: 609-621.
12. Sepracor, Inc (2009). Safety and efficacy of eslicarbazepine acetate monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs. NCT trial Number NCT866775. Available at website:. Accessed January 2, 2010.
13. Stolk P, Ten Berg MJ, Hemels ME, Einarson TR,. (2003) Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother 37: 1891-1899.
14. Sysko R, Walsh BT,. (2007) A systematic review of placebo response in studies of bipolar mania. J Clin Psychiatry 68: 1213-1217.
15. UCB, Inc. (2009a) Conversion to monotherapy study with Keppra XR for partial seizures. NCT trial Number NCT419094. Available at website:. Accessed January 2, 2010.
16. UCB, Inc. (2009b) Trial to demonstrate the efficacy and safety of conversion to lacosamide monotherapy for partial-onset seizures (ALEX-MT). NCT Trial Number 520741. Available at website:. Accessed January 2, 2010.
17. UCB, Inc. (2009c) A double-blind, randomized conversion to monotherapy study to evaluate the efficacy and safety of brivaracetam in subjects (≥ 16 to 75 Years Old) with partial onset seizures. NCT Trial Number 698581. Available at website:. Accessed January 2, 2010.
18. UCB, Inc. (2009d) A double-blind, randomized conversion to monotherapy study to evaluate the efficacy and safety of brivaracetam in subjects (≥ 16 to 75 Years Old) with partial onset seizures. NCT Trial Number 699283. Available at website:. Accessed on January 2, 2010.
19. Walsh BT, Seidman SN, Sysko R, Gould M,. (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA 10: 287. 1840-1847.